Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Aug 11, 2015 10:25am
75 Views
Post# 24006646

RE:Where is this going?

RE:Where is this going?
gv, that would be a stretch (re. sub $0.50) but anywhere down to $1.00 is possible..i was a bit surprised $1.60 didn't hold but it tells me there is no support from buyers at that level which indicates further expectations of a price cratering...no surprise remember who the CEO is and how RVX has treated shareholders before, it shoulda been easy to keep the price above $1.60 but alas it is consistent with the RVX failures of the past...ps i wonder if that toy company Zenith has been completely mothballed or more likely is CEO'ing two companies effectively way, way, way, way beyond the competence of DM..i wonder if at a $1.00 Hepa takes a run for full control???
Bullboard Posts